| Product Code: ETC13309598 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Emesis Market was valued at USD 0.7 Billion in 2024 and is expected to reach USD 1.3 Billion by 2031, growing at a compound annual growth rate of 6.77% during the forecast period (2025-2031).
The Global Emesis Market is witnessing steady growth driven by factors such as the rising prevalence of conditions causing nausea and vomiting, such as chemotherapy-induced nausea, motion sickness, and pregnancy-related morning sickness. The market encompasses various products including antiemetic drugs, medical devices like acupressure bands, and natural remedies. The increasing adoption of antiemetic medications and the development of novel formulations with improved efficacy are contributing to market expansion. Furthermore, the growing awareness about the importance of managing emesis in patients undergoing various treatments is driving the demand for emesis control products. The market is characterized by key players focusing on research and development activities to introduce innovative solutions, enhancing the overall treatment outcomes for patients experiencing nausea and vomiting.
The global emesis market is experiencing steady growth due to increasing cases of nausea and vomiting across various age groups. The market is witnessing a significant shift towards the development of more effective and patient-friendly antiemetic drugs, as well as innovative delivery systems such as transdermal patches and oral dissolving films. Furthermore, the rise in chemotherapy treatments and the growing demand for motion sickness medications are driving the market growth. Opportunities in the market include expanding product portfolios to cater to different therapeutic areas, investing in research and development to introduce novel formulations, and focusing on emerging markets with high unmet medical needs. Overall, the market is poised for continued growth as healthcare providers and pharmaceutical companies strive to address the diverse needs of patients experiencing emesis.
The Global Emesis Market faces several challenges, including the lack of effective and universally accepted treatment options for nausea and vomiting, leading to a need for continuous research and development efforts. Additionally, regulatory hurdles and compliance issues in different regions pose challenges for market players looking to expand globally. The stigma associated with emesis-related conditions also hinders patient willingness to seek treatment and impacts market growth. Moreover, the competitive landscape with a limited number of key players dominating the market intensifies the challenge for newer entrants to establish a significant market presence. Overall, addressing these challenges will require innovation, collaboration between stakeholders, and a focus on improving patient outcomes in the Global Emesis Market.
The global emesis market is primarily driven by the increasing prevalence of conditions such as motion sickness, morning sickness in pregnant women, chemotherapy-induced nausea, and other gastrointestinal disorders. Factors such as the growing aging population, rising incidence of chronic diseases, and increasing awareness about available treatment options are also contributing to market growth. Additionally, advancements in healthcare infrastructure, the development of novel antiemetic drugs, and the expansion of distribution networks in emerging economies are further fueling the market. The demand for effective and convenient treatment options for nausea and vomiting is expected to continue driving the growth of the global emesis market in the coming years.
Government policies related to the Global Emesis Market focus on regulating the production, distribution, and marketing of emesis-inducing medications to ensure safety, efficacy, and proper usage. Regulatory bodies such as the FDA in the United States and the EMA in Europe set standards for product approval, labeling requirements, and post-market surveillance. These policies aim to prevent misuse, adverse effects, and fraudulent practices in the emesis market, promoting public health and consumer protection. Additionally, governments may implement pricing and reimbursement policies to control costs and improve access to emetic drugs for patients in need. Overall, government regulations play a crucial role in shaping the emesis market landscape and ensuring the quality and availability of these important medical products.
The Global Emesis Market is expected to witness steady growth in the coming years due to the rising prevalence of conditions such as motion sickness, morning sickness, chemotherapy-induced nausea, and other gastrointestinal disorders. The market is likely to be driven by the increasing demand for antiemetic drugs, as well as the development of innovative treatment options and drug delivery systems. Additionally, the growing geriatric population and increasing awareness about the importance of managing nausea and vomiting are anticipated to contribute to market growth. Technological advancements in the pharmaceutical industry and the emphasis on patient-centric care are also expected to shape the future outlook of the Global Emesis Market positively. However, regulatory challenges, pricing pressures, and competition among key market players may pose challenges to market expansion.
The global emesis market shows varying trends across different regions. In Asia, the market is expected to witness significant growth due to the increasing prevalence of gastrointestinal disorders and the rising adoption of advanced healthcare technologies. North America, on the other hand, holds a prominent position in the emesis market with a strong presence of key market players and well-established healthcare infrastructure. In Europe, the market is characterized by stringent regulations and increasing investments in research and development activities. The Middle East and Africa region is anticipated to experience steady growth driven by improving healthcare facilities and rising awareness about gastrointestinal disorders. Latin America shows potential for market expansion due to the growing healthcare expenditure and increasing demand for emesis management solutions.
Global Emesis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Emesis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Emesis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Emesis Market - Industry Life Cycle |
3.4 Global Emesis Market - Porter's Five Forces |
3.5 Global Emesis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Emesis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Emesis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Global Emesis Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Emesis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Emesis Market Trends |
6 Global Emesis Market, 2021 - 2031 |
6.1 Global Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Emesis Market, Revenues & Volume, By Antihistamines, 2021 - 2031 |
6.1.3 Global Emesis Market, Revenues & Volume, By Serotonin Receptor Antagonists, 2021 - 2031 |
6.1.4 Global Emesis Market, Revenues & Volume, By Dopamine Receptor Antagonists, 2021 - 2031 |
6.1.5 Global Emesis Market, Revenues & Volume, By Neurokinin Receptor Antagonists, 2021 - 2031 |
6.1.6 Global Emesis Market, Revenues & Volume, By Anticholinergics, 2021 - 2031 |
6.1.7 Global Emesis Market, Revenues & Volume, By Other Drug Types, 2021 - 2031 |
6.2 Global Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Emesis Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.2.3 Global Emesis Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.2.4 Global Emesis Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.3 Global Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Emesis Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.3.3 Global Emesis Market, Revenues & Volume, By Post Operative Surgery, 2021 - 2031 |
6.3.4 Global Emesis Market, Revenues & Volume, By Pregnancy and Gatroenteritis, 2021 - 2031 |
6.3.5 Global Emesis Market, Revenues & Volume, By Other Applications, 2021 - 2031 |
7 North America Emesis Market, Overview & Analysis |
7.1 North America Emesis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Emesis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Emesis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Emesis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5 North America Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Emesis Market, Overview & Analysis |
8.1 Latin America (LATAM) Emesis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Emesis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Emesis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Emesis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Emesis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.5 Latin America (LATAM) Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Emesis Market, Overview & Analysis |
9.1 Asia Emesis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Emesis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Emesis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Emesis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Emesis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.5 Asia Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Emesis Market, Overview & Analysis |
10.1 Africa Emesis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Emesis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Emesis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Emesis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Emesis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.5 Africa Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Emesis Market, Overview & Analysis |
11.1 Europe Emesis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Emesis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Emesis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Emesis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Emesis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.5 Europe Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Emesis Market, Overview & Analysis |
12.1 Middle East Emesis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Emesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Emesis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Emesis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Emesis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Emesis Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Emesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.5 Middle East Emesis Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Emesis Market Key Performance Indicators |
14 Global Emesis Market - Export/Import By Countries Assessment |
15 Global Emesis Market - Opportunity Assessment |
15.1 Global Emesis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Emesis Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Emesis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.4 Global Emesis Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Emesis Market - Competitive Landscape |
16.1 Global Emesis Market Revenue Share, By Companies, 2024 |
16.2 Global Emesis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here